Altered expression of alpha-subunits of G proteins in failing human hearts

Journal of Molecular and Cellular Cardiology
A M FeldmanC Van Dop

Abstract

We have recently demonstrated that the activity of the inhibitory guanine nucleotide-binding regulatory protein Gi is increased in the hearts of patients with idiopathic dilated cardiomyopathy. We determined whether altered Gi protein levels in the failing human heart correlate with changes in steady state levels of the mRNA encoding one of the alpha Gi peptides. cDNAs encoding alpha Gs, alpha Go, and three subspecies of alpha Gi were used as hybridization probes to quantify steady state levels of mRNA encoding these alpha G peptides in failing and non-failing human heart. The lengths of the mRNAs that encode each alpha G peptide were the same in non-failing and failing hearts. Steady state levels of mRNA encoding both alpha Gi-3 and alpha Gs were significantly increased in the failing hearts when compared to non-failing hearts. By contrast, there was no significant change in the levels of mRNA encoding alpha Go or of rRNA. The relative abundance of the mRNA encoding each of the subspecies of alpha Gi was different in the human heart; alpha Gi-3 mRNA was abundant, alpha Gi-2 was barely detectable, and we were not able to detect alpha Gi-1 utilizing our hybridization conditions. These results suggest that alterations at the leve...Continue Reading

Citations

Aug 1, 1993·Pflügers Archiv : European journal of physiology·P MansierB Swynghedauw
Nov 15, 1994·The American Journal of Cardiology·U SchmidtE Erdmann
Dec 1, 1993·Pharmacology & Therapeutics·O E Brodde
Apr 1, 1991·Brain Research. Molecular Brain Research·P J HarrisonR C Pearson
Oct 2, 2003·Journal of Molecular and Cellular Cardiology·Clemens MittmannThomas Eschenhagen
Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P W LadensonA M Feldman
Oct 25, 2003·Journal of Cardiovascular Pharmacology·Jason D KiltsMadan M Kwatra
Jan 1, 1990·British Journal of Clinical Pharmacology·P MansierB Swynghedauw
May 20, 1999·Annual Review of Pharmacology and Toxicology·S R PostP A Insel
Feb 22, 2001·Annual Review of Physiology·J D Molkentin, G W Dorn
Apr 29, 1998·Aging : Clinical and Experimental Research·N FerraraS E Harding
Apr 25, 2000·Journal of Molecular and Cellular Cardiology·J D BisognanoD J Port
Nov 5, 2003·Journal of Cellular and Molecular Medicine·R SethiN S Dhalla
Jun 25, 1998·Japanese Journal of Pharmacology·J ShibuyaT Iwasaki
Nov 23, 1992·FEBS Letters·C Thibault, M B Anand-Srivastava
Feb 1, 1992·Circulation·J W FlemingA M Watanabe
Sep 27, 2005·Physiological Reviews·Nina Wettschureck, Stefan Offermanns
Dec 13, 2017·PloS One·Ashley N GuilloryCeleste C Finnerty
Sep 1, 1996·Cellular Signalling·P Schnabel, M Böhm

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.